MINDY KAZERY: Open Payments
NPI 1164804209 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 9 payments from 6 companies in 2025. Trend: 2023 $74 · 2024 $48 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
Products named: CAPLYTA, REXULTI, AUSTEDO XR, Dexcom G6 Transmitter, Symbravo.
Industry payments across AR — which companies pay providers there.
